Sarah Kate Frey is no stranger to adversity. At just 12 years old, she returned home from horseback riding camp with a painful sore throat and a high fever. The horse she had been riding at camp died that same night. Frey was diagnosed with a staph infection, which took an unusually long time to
Cancer
3D rendering of blood cancer Cancer Research UK is collaborating with Aleta Biotherapeutics (Aleta) to trial a new therapy that ‘reboots’ a treatment for some people with blood cancer whose cancer starts to come back. The new therapy, called ALETA-001, aims to boost a treatment called CAR T-cell therapy, which takes some of a patient’s
Gillian Spence first noticed a suspicious lump in her chest at one of the most inconvenient possible times. She was just days away from her wedding day. She immediately scheduled an appointment to see her doctor. “In between fake tan and getting my nails done, I was fitting in MRIs and blood tests,” the 31-year-old
Sustainable gardening doesn’t have a firm, technical definition. It’s the concept of using sustainable gardening techniques that not only cause no harm to the environment, but also typically tend to improve and enhance your garden. Though no one is perfect, and it is near-impossible to practice sustainable garden techniques 100% of the time, any changes
It’s a great day for cancer survivors. The Supreme Court of the United States (SCOTUS) upheld the Affordable Care Act (ACA), commonly known as Obamacare. This means The ACA is still the law of the land. Folks who rely on the ACA Marketplace or their state-based exchanges will continue to have access to purchase health
Cancer Research UK’s spin-out, GammaDelta Therapeutics (‘GammaDelta’), has been given approval from the US Food and Drug Administration (FDA) to trial its unique T-cell therapy in humans. The trial is expected to begin later this year in the United States and will test the safety and early indications of efficacy of the cell therapy in
Many cancer patients use alternative or complementary therapies in conjunction with their main course of treatment, but a new survey shows that many oncologists underestimate how many of their patients are using these types of therapies. It also appears that oncologists and patients disagree about how effective each type of alternative therapy may be. Complementary
New figures show 42.1% of people surveyed in Wales who experienced possible cancer symptoms in the first wave of the pandemic didn’t contact their GP. In response, Cancer Research UK has launched Don’t Ignore It, a major awareness campaign urging people to contact their doctor if they are concerned about their health. Michelle Mitchell, chief
Talking about a virus is all a lot of us seem to be doing at the moment. We’re happy enough chatting away about COVID-19 and other common viruses like the cold or flu, so why is there so little conversation about HPV? You may have heard about HPV, human papillomavirus, as the virus linked to
Credit: Southampton Clinical Trials Unit The first participants have taken part in a new research trial that aims to save lives by detecting lung cancer at an earlier stage when it is more treatable. People attending the NHS Targeted Lung Health Checks in Southampton are being invited to take part in the iDx Lung trial,
A dangerous chemical substance is being used in common household products. It’s been linked to myriad health issues in adults, children, and even unborn babies, and it was once approved for use by the FDA. Bisphenol A (BPA) has been known to negatively affect fetal and infant brain development, as well as interfere with memory
Bowel cancer cells under a microscope. People who have previously been treated for a type of bowel cancer that has spread to other parts of their body will now have another treatment option in England, following the approval of the combined use of nivolumab (Opdivo) and ipilimumab (Yervoy) for these patients. The National Institute of
Around 10,600 fewer breast cancer patients have started treatment in the last year in England. Breast cancer deaths reached an all-time low before the pandemic, but experts fear these new stats show that this hard-won progress could slow. The charity estimates around 38,000 fewer people started treatment for all cancer types in England. And breast
The businessman, philanthropist and long-standing Cancer Research UK supporter tells us about his family’s latest £1.2m donation. At first glance, Cancer Research UK might not seem the obvious charity of choice for a family of philanthropists historically committed to supporting education. Until recently, their many beneficiaries chiefly comprised universities, libraries and schools. But for David
Amy Burritt and Cheri Intveld started out as best friends, and they have been best friends for about 20 years. Then they decided to be business partners and opened a specialty cheese shop together. What they never expected, however, is that they’d end up being cancer patients together too, and while they were only in
JoAnn Carroll lives in South Carolina, but she’s been self-evacuated to her condo in Florida for the last few months as she waits for the air in and around her home to become cleaner and more breathable. When JoAnn and her husband first left for the condo in January, she says there was no issue.
June is National Cancer Survivors Month! To honor survivors, we will be sharing stories from folks with cancer and their caregivers. Today we hear from Marlys. It was the sunny month of July. We were sharing a vacation rental with our daughter, son-in-law, and the grandkids in a nearby mountain village. My husband’s cancer was
Screening tests mark a turning point in early detection of cancers. The first screening test widely used to detect cancer, developed by George Papanicolaou, was the Pap test. Although Papanicolaou presented his findings in 1923, it wasn’t until the early 1960s, when the Pap test was backed by the American Cancer Society (ACS), that doctors
Lung adenocarcinoma cells, a type of non small cell lung cancer (NSCLC) One of the biggest meetings of the world’s cancer specialists took place this weekend. Usually located in Chicago, researchers and clinicians around the world met virtually this year to present the latest in cancer research at the American Society of Clinical Oncology (ASCO)
Breast cancer is essentially incapable of taking a life as long as it stays in a person’s breasts and doesn’t spread to other areas of the body. When it metastasizes to important organs like the liver, lungs, bones, or brain, however, it can have disastrous consequences. Therefore, it’s important that breast cancer research emphasizes understanding
Prostate cancer cells. Prostate cancer cells viewed under a microscope. Men with advanced, hormone-sensitive prostate cancer will now have another treatment option in England, following the approval of the hormone therapy enzalutamide (Xtandi). The National Institute of Health and Care Excellence (NICE) has approved the combination of enzalutamide and androgen deprivation therapy (ADT) for adults
Triple negative breast cancer (TNBC) lacks all three of the common receptors found in breast cancer, which makes it harder to treat. The disease also spreads faster and has a worse prognosis. A new study out of Canada may have found a better treatment option for it, though. In a preclinical study, a team from
Breast cancer recurrence is a strong concern of patients after their initial treatment ends. There may be some good news on this front for those with mutations that make them higher-risk. British drug manufacturer AstraZeneca shared promising results of the OlympiA Phase III trial on its cancer drug Lynparza in The New England Journal of
A husband grieving the loss of his wife to breast cancer was left with an unused package of her medication. Not wanting to see that reminder and hoping to help other breast cancer patients, he asked if he could donate the prescription to someone in need. Unfortunately, no one would allow it. Ed Casaccia lost
June is National Cancer Survivors Month! To honor survivors, we will be sharing stories from folks with cancer and their caregivers. Today we hear from Erin. 37-Year-Old Cancer Survivor and Mom of Four Shares Her Survival Story to Help Others An advanced Stage III colon cancer diagnosis was the last thing I expected to receive
For the next stop on our virtual tour around the UK meeting the directors of our research centres and institutes, we speak with Professor Ian Tomlinson, who heads up the Cancer Research UK Edinburgh Centre. When geneticist and clinician researcher Professor Ian Tomlinson took over as director of our Cancer Research UK Edinburgh Centre in
Our partnership with ScottishPower began in 2012, since then it’s raised over £30m. We’re thrilled to announce that we’re extending this extraordinary partnership for another three years. This means that the incredible employees, suppliers and customers of ScottishPower will continue to help us fund our life-saving research until 31 March 2024. Alongside their creative fundraising
A patient website that supports cancer patients and their family caregivers Confronting a cancer diagnosis is one of the most demanding, isolating things you can do. Family and friends are an amazing source of support, but constantly sharing updates with each and every one of them is impractical. So what resources are available to families
- « Previous Page
- 1
- …
- 20
- 21
- 22
- 23
- 24
- …
- 40
- Next Page »